How to manage osteoporosis in hematologic stem cell transplant recipients
New gene editing strategies developed for Duchenne muscular dystrophy
3 May 2021New findings on barriers and support in global fight against tuberculosis
3 May 2021How to manage osteoporosis in hematologic stem cell transplant recipients
Impaired bone health is among the most significant long-term consequences of hematopoietic stem cell transplantation (HSCT), a common therapy for patients with malignant and non-malignant hematological diseases.
